MX2017006537A - Anticuerpos contra metabolitos de serotonina, triptofano y cinurenina, y usos de los mismos. - Google Patents

Anticuerpos contra metabolitos de serotonina, triptofano y cinurenina, y usos de los mismos.

Info

Publication number
MX2017006537A
MX2017006537A MX2017006537A MX2017006537A MX2017006537A MX 2017006537 A MX2017006537 A MX 2017006537A MX 2017006537 A MX2017006537 A MX 2017006537A MX 2017006537 A MX2017006537 A MX 2017006537A MX 2017006537 A MX2017006537 A MX 2017006537A
Authority
MX
Mexico
Prior art keywords
antibodies
tryptophan
metabolites
antibodies against
hiaa
Prior art date
Application number
MX2017006537A
Other languages
English (en)
Inventor
Singh Sharat
Selvaraj Fabiyola
Princen Fred
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2017006537A publication Critical patent/MX2017006537A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención proporciona anticuerpos y métodos para preparar anticuerpos contra metabolitos en las vías de serotonina, triptófano y cinurenina, tales como ácido 5-hidroxiindol-3-acético (5-HIAA), melatonina (MT) y ácido cinurénico (KYNA). Los anticuerpos de metabolitos específicos tienen baja reactividad cruzada con metabolitos estructuralmente relacionados, y son reactivos útiles para inmunoensayos específicos y sensibles. La presente invención también proporciona métodos para usar tales anticuerpos para medir los niveles de 5-HIAA, melatonina o ácido cinurénico en muestras biológicas de pacientes humanos.
MX2017006537A 2014-11-19 2015-11-19 Anticuerpos contra metabolitos de serotonina, triptofano y cinurenina, y usos de los mismos. MX2017006537A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462082047P 2014-11-19 2014-11-19
PCT/IB2015/058976 WO2016079708A1 (en) 2014-11-19 2015-11-19 Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof

Publications (1)

Publication Number Publication Date
MX2017006537A true MX2017006537A (es) 2017-08-09

Family

ID=54705246

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006537A MX2017006537A (es) 2014-11-19 2015-11-19 Anticuerpos contra metabolitos de serotonina, triptofano y cinurenina, y usos de los mismos.

Country Status (11)

Country Link
US (1) US20170240652A1 (es)
EP (1) EP3221353A1 (es)
JP (1) JP2018501202A (es)
KR (1) KR20170080701A (es)
CN (1) CN107257805A (es)
AU (1) AU2015348940A1 (es)
CA (1) CA2968338A1 (es)
IL (1) IL252110A0 (es)
MX (1) MX2017006537A (es)
SG (1) SG11201703729RA (es)
WO (1) WO2016079708A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018044724A1 (en) * 2016-08-31 2018-03-08 Ampio Pharmaceuticals, Inc. Treatment of disease with n-acetyl kynurenine
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
CN107290517A (zh) * 2017-06-28 2017-10-24 南通大学 一种人体毛发褪黑素含量的测量方法
KR102699211B1 (ko) 2018-03-19 2024-08-26 후지필름 가부시키가이샤 정신 질환의 판정 방법
KR102214571B1 (ko) * 2019-08-05 2021-02-09 한국과학기술연구원 알코올 중독의 진단용 조성물, 키트 및 이를 이용한 알코올 중독의 진단을 위한 키누렌산의 검출 방법
CN116177498B (zh) * 2022-12-12 2023-11-24 江南大学 一种具有光响应的手性硒纳米薄膜及其制备方法与其在检测l-犬尿氨酸中的应用
CN116731165B (zh) * 2023-03-23 2024-08-13 北京巴瑞医疗器械有限公司 一种抗血清素抗体及其应用
CN116990498B (zh) * 2023-09-28 2024-08-09 山东大学齐鲁医院 血浆色氨酸代谢物在儿童偏头痛诊断中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
WO1994004690A1 (en) 1992-08-17 1994-03-03 Genentech, Inc. Bispecific immunoadhesins
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
WO2007075931A2 (en) * 2005-12-22 2007-07-05 Biosite Incorporated Reactive heterocyclic derivatives and methods for their synthesis and use
JP2013511544A (ja) * 2009-11-23 2013-04-04 レクシコン ファーマシューティカルズ インコーポレイテッド 過敏性腸症候群を治療するための方法及びアッセイ
EP3004892B1 (en) 2013-05-24 2018-10-10 Nestec S.A. Method for diagnosing irritable bowel syndrome

Also Published As

Publication number Publication date
WO2016079708A1 (en) 2016-05-26
IL252110A0 (en) 2017-07-31
SG11201703729RA (en) 2017-06-29
CN107257805A (zh) 2017-10-17
AU2015348940A1 (en) 2017-05-25
EP3221353A1 (en) 2017-09-27
CA2968338A1 (en) 2016-05-26
US20170240652A1 (en) 2017-08-24
JP2018501202A (ja) 2018-01-18
KR20170080701A (ko) 2017-07-10

Similar Documents

Publication Publication Date Title
MX2017006537A (es) Anticuerpos contra metabolitos de serotonina, triptofano y cinurenina, y usos de los mismos.
IL268974B (en) Labeled inhibitors of prostate-specific membrane antigen (psma), their use as imaging agents and as pharmaceutical agents for the treatment of prostate cancer
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
MX2015010480A (es) Analisis de imagen y medicion de muestras biologicas.
CY1118187T1 (el) Χημικες ενωσεις
TW201613962A (en) Fabs-in-tandem immunoglobulin and uses thereof
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201692201A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
BR112015001592A8 (pt) análise de imagem e medidas de amostras biológicas
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
EA201400412A1 (ru) ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
PH12016501366A1 (en) Novel anti-baff antibodies
WO2015176066A3 (en) Lpa-associated protein and rna expression
PT4095130T (pt) Inibidores marcados do antígeno de membrana específico da próstata (psma), seu uso como agentes de imagem e agentes farmacêuticos para o tratamento do cancro da próstata
MX336109B (es) Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo.
EP3215829A4 (en) Compositions, apparatus and methods for determining alkalinity of an analyte solution
EA201790445A1 (ru) Производные индолинона и их применение
WO2014205342A3 (en) Methods for treatment of ovarian cancer
MX2017005650A (es) Composicion de antigeno para detectar enfermedad de chagas.
MX2016017136A (es) Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
GB2530521B (en) Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin
EP4328245A3 (en) Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
EA201401218A3 (ru) Способ нозологической экспресс-диагностики
UA117286C2 (uk) 2-гетарил-2-(n-r-піролідин-2-іліден)ацетонітрили та спосіб їх отримання (варіанти)